Immuno-oncology has revolutionized cancer treatment and has opened up new
opportunities for developing vaccination methods. DNA-based cancer vaccines have …

Prostate cancer (PCa) remains both a global health burden and a scientific challenge. We
present a review of the molecular targets driving current drug discovery to fight this disease …

Purpose: Enzalutamide after abiraterone progression is commonly used in metastatic
castration-resistant prostate cancer despite a low rate of clinical benefit. Analyzing …

The clinical success of combined androgen deprivation therapy (ADT) and radiotherapy
(RT) in prostate cancer created interest in understanding the mechanistic links between …

Androgen deprivation therapy has achieved significant success in treating prostate cancer
through strategies centered on the androgen receptor. However, the emergence of …

Context Mutations in the speckle-type POZ (SPOP) gene are frequently identified in prostate
cancer (PC); yet, prognostic implications for affected patients remain unclear. Limited …

Simple Summary In this review, we will analyze the main mutations predominant in the
various histotypes of salivary gland carcinomas, we will discover whether they behave as …

Receptor androgenowy po związaniu z ligandem pełni rolę czynnika transkrypcyjnego, który
w ostatecznym efekcie pomaga utrzymać prawidłową strukturę i funkcję prostaty. W raku …